|
[1]
|
Wang, F., Yao, X., Zhang, Y., et al. (2019) Synthesis, Biological Function and Evaluation of Shikonin in Cancer Therapy. Fitoterapia, 134, 329-339. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Andújar, I., Ríos, J., Giner, R., et al. (2013) Pharmacological Properties of Shikonin: A Review of Literature since 2002. Planta Medica, 79, 1685-1697. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Piao, J., Cui, Z., Furusawa, Y., et al. (2013) The Mo-lecular Mechanisms and Gene Expression Profiling for Shikonin-Induced Apoptotic and Necroptotic Cell Death in U937 Cells. Chemico-Biological Interactions, 205, 119-127. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Lu, B., Gong, X., Wang, Z.Q., et al. (2017) Shikonin Induces Glioma Cell Necroptosis in Vitro by ROS Overproduction and Promoting RIP1/RIP3 Necrosome Formation. Acta Pharmaceutica Sinica, 38, 1543-1553. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Han, W., Li, L., Qiu, S., et al. (2007) Shikonin Circumvents Cancer Drug Resistance by Induction of a Necroptotic Death. Molecular Cancer Therapeutics, 6, 1641-1649. [Google Scholar] [CrossRef]
|
|
[6]
|
Zhang, Y., Han, H., Sun, L., et al. (2017) Antiviral Activity of Shikonin Ester Derivative PMM-034 against Enterovirus 71 in Vitro. Brazilian Journal of Medical and Biological Research, 50, e6586. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Zhang, Y., Han, H., Qiu, H., et al. (2017) Antiviral Activity of a Synthesized Shikonin Ester against Influenza A (H1N1) Virus and Insights into Its Mechanism. Biomedicine & Pharmacotherapy, 93, 636-645. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Chen, X., Yang, L., Zhang, N., et al. (2003) Shikonin, a Component of Chinese Herbal Medicine, Inhibits Chemokine Receptor Function and Suppresses Human Immunodeficiency Virus Type 1. Antimicrobial Agents and Chemotherapy, 47, 2810-2816. [Google Scholar] [CrossRef]
|
|
[9]
|
Lee, Y., Lee, D., Kim, Y., et al. (2015) The Mechanism Underlying the Antibacterial Activity of Shikonin against Methicillin-Resistant Staphylococcus aureus. Evidence-Based Complementary and Alternative Medicine, 2015, Article ID: 520578. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Issa, F., Schiopu, A. and Wood, K.J. (2010) Role of T Cells in Graft Rejection and Transplantation Tolerance. Journal Expert Review of Clinical Immunology, 6, 155-169. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Zeng, Q., Qiu, F., Chen, Y., et al. (2019) Shikonin Prolongs Allograft Survival via Induction of CD4(+) FoxP3(+) Regulatory T Cells. Frontiers in Immunology, 10, 652. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Dai, Q., Fang, J. and Zhang, F. (2009) Dual Role of Shikonin in Early and Late Stages of Collagen Type II Arthritis. Molecular Biology Reports, 36, 1597-1604. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Lu, S.L., Dang, G.H., Deng, J.C., et al. (2020) Shikonin Attenuates Hyperhomocysteinemia-Induced CD4(+) T Cell Inflammatory Activation and Atherosclerosis in ApoE(-/-) Mice by Metabolic Suppression. Acta Pharmaceutica Sinica, 41, 47-55. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Li, T., Yan, F., Wang, R., et al. (2013) Shikonin Suppresses Human T Lymphocyte Activation through Inhibition of IKK beta Activity and JNK Phosphorylation. Evidence-Based Complementary and Alternative Medicine, 2013, Article ID: 379536. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Wang, H., Tang, Y., Fang, Y., et al. (2019) Reprogramming Tumor Immune Microenvironment (TIME) and Metabolism via Biomimetic Targeting Codelivery of Shikonin/JQ1. Nano Letters, 19, 2935-2944. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Yin, S., Efferth, T., Jian, F., et al. (2016) Immunogenicity of Mammary Tumor Cells Can Be Induced by Shikonin via Direct Binding-Interference with hnRNPA1. Oncotarget, 7, 43629-43653. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Lin, T.J., Lin, H.T., Chang, W.T., et al. (2015) Shikonin-Enhanced Cell Immunogenicity of Tumor Vaccine Is Mediated by the Differential Effects of DAMP Components. Molecular Cancer, 14, 174. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Chen, H.M., Wang, P.H., Chen, S.S., et al. (2012) Shikonin In-duces Immunogenic Cell Death in Tumor Cells and Enhances Dendritic Cell-Based Cancer Vaccine. Cancer Immu-nology, Immunotherapy, 61, 1989-2002. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Constant, S.L., Brogdon, J.L., Piggott, D.A., et al. (2002) Resi-dent Lung Antigen-Presenting Cells Have the Capacity to Promote Th2 T Cell Differentiation in Situ. The Journal of Clinical Investigation, 110, 1441-1448. [Google Scholar] [CrossRef]
|
|
[20]
|
Lee, C.C., Wang, C.N., Lai, Y.T., et al. (2010) Shikonin Inhibits Maturation of Bone Marrow-Derived Dendritic Cells and Suppresses Allergic Airway Inflammation in a Murine Model of Asthma. British Journal of Pharmacology, 161, 1496-1511. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Chiu, S.C., Tsao, S.W., Hwang, P.I., et al. (2010) Differential Functional Genomic Effects of Anti-Inflammatory Phytocompounds on Immune Signaling. BMC Genomics, 11, Article No. 513. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Cheng, Y.W., Chang, C.Y., Lin, K.L., et al. (2008) Shikonin Derivatives Inhibited LPS-Induced NOS in RAW 264.7 Cells via Down-Regulation of MAPK/NF-kappaB Signaling. Journal of Ethnopharmacology, 120, 264-271. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Lu, L., Qin, A., Huang, H., et al. (2011) Shikonin Extracted from Medicinal Chinese Herbs Exerts Anti-Inflammatory Effect via Proteasome Inhibition. European Journal of Pharma-cology, 658, 242-247. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Yoshida, L.S., Kawada, T., Irie, K., et al. (2010) Shikonin Di-rectly Inhibits Nitric Oxide Synthases: Possible Targets That Affect Thoracic Aorta Relaxation Response and Nitric Oxide Release from RAW 264.7 Macrophages. Journal of Pharmacological Sciences, 112, 343-351. [Google Scholar] [CrossRef]
|
|
[25]
|
Andújar, I., Ríos, J.L., Giner, R.M., et al. (2012) Beneficial Effect of Shikonin on Experimental Colitis Induced by Dextran Sulfate Sodium in BALB/c Mice. Evidence-Based Complemen-tary and Alternative Medicine, 2012, Article ID: 271606. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Wang, X.Q., Yu, J., Luo, X.Z., et al. (2010) The High Level of RANTES in the Ectopic Milieu Recruits Macrophages and Induces Their Tolerance in Progression of Endometriosis. Journal of Molecular Endocrinology, 45, 291-299. [Google Scholar] [CrossRef]
|
|
[27]
|
Yuan, D.P., Gu, L., Long, J., et al. (2014) Shikonin Reduces Endometriosis by Inhibiting RANTES Secretion and Mononuclear Macrophage Chemotaxis. Experimental and Therapeutic Medicine, 7, 685-690. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Li, Y., Lu, H., Gu, Y., et al. (2017) Enhancement of NK Cells Proliferation and Function by Shikonin. Immunopharmacology and Immunotoxicology, 39, 124-130. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Su, L., Yan, G.Z., et al. (2012) Shikonin Derivatives Pro-tect Immune Organs from Damage and Promote Immune Responses in Vivo in Tumour-Bearing Mice. Phytotherapy Research, 26, 26-33. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Chen, X., Yang, L., Oppenheim, J.J., et al. (2002) Cellular Pharmacology Studies of Shikonin Derivatives. Phytotherapy Research, 16, 199-209. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Papageorgiou, V.P., Assimopoulou, A.N., Couladouros, E.A., et al. (1999) The Chemistry and Biology of Alkannin, Shikonin, and Related Naphthazarin Natural Products. Angewandte Chemie, 38, 270-301. [Google Scholar] [CrossRef]
|
|
[32]
|
Krawczyk, C.M., Holowka, T., Sun, J., et al. (2010) Toll-Like Receptor-Induced Changes in Glycolytic Metabolism Regulate Dendritic Cell Activation. Blood, 115, 4742-4749. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Galván-Peña, S. and O’neill, L.A. (2014) Metabolic Reprograming in Macrophage Polarization. Frontiers in Immunology, 5, 420. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Li, W., Liu, J., Jackson, K., et al. (2014) Sensitizing the Thera-peutic Efficacy of Taxol with Shikonin in Human Breast Cancer Cells. PLoS ONE, 9, e94079. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Kunisawa, J., Sugiura, Y., Wake, T., et al. (2015) Mode of Bioenergetic Metabolism during B Cell Differentiation in the Intestine Determines the Distinct Requirement for Vita-min B1. Cell Reports, 13, 122-131. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Chen, J., Xie, J., Jiang, Z., et al. (2011) Shikonin and Its Ana-logs Inhibit Cancer Cell Glycolysis by Targeting Tumor Pyruvate Kinase-M2. Oncogene, 30, 4297-4306. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Wang, Y., Zhou, Y., Jia, G., et al. (2014) Shikonin Suppresses Tumor Growth and Synergizes with Gemcitabine in a Pancreatic Cancer Xenograft Model: Involvement of NF-κB Signaling Pathway. Biochemical Pharmacology, 88, 322-333. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Wang, H., Tang, Y., Fang, Y., et al. (2019) Reprogramming Tumor Immune Microenvironment (TIME) and Metabolism via Bi-omimetic Targeting Codelivery of Shikonin/JQ1. Nano Letters, 19, 2935-2944. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Shilnikova, K., Piao, M.J., Kang, K.A., et al. (2018) Shikonin Induces Mitochondria-Mediated Apoptosis and Attenuates Epithelial-Mesenchymal Transition in Cisplatin-Resistant Human Ovarian Cancer Cells. Oncology Letters, 15, 5417-5424. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Ni, F., Huang, X., Chen, Z., et al. (2018) Shikonin Exerts Antitumor Activity in Burkitt’s Lymphoma by Inhibiting C-MYC and PI3K/AKT/mTOR Pathway and Acts Synergistically with Doxorubicin. Scientific Reports, 8, Article No. 3317. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Li, Y.L., Hu, X., Li, Q.Y., et al. (2018) Shikonin Sensitizes Wild-Type EGFR NSCLC Cells to Erlotinib and Gefitinib Therapy. Molecular Medicine Reports, 18, 3882-3890. [Google Scholar] [CrossRef] [PubMed]
|